Application value of pressing needle therapy in perioperative anesthesia and analgesia of one-lung ventilation thoracoscopic surgery

Not Applicable

• Conditions: ung cancer

• Registration Number: ITMCTR2100005031
• Lead Sponsor: Jiangsu Cancer Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. At least 18 years old;
2. Planned elective thoracoscopic-assisted radical unilateral lung cancer resection (lobectomy, segmental resection or wedge resection);
3. ASA classification I-III;
4. BMI <30kg/m^2;
5. Sign the informed consent.

Exclusion Criteria

1. Preoperative pulmonary function test indicates severe ventilation or ventilation dysfunction (FVC <80% predicted value or FEV1 <70% predicted value);
2. Complicated with severe liver and kidney insufficiency, autoimmune disease, immunodeficiency disease, or used immunosuppressive therapy within 6 months before surgery;
3. Complicated with chronic obstructive pulmonary disease, asthma, or a history of respiratory tract infection within 1 month.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HIF-1 alpha;Analgesic use;Postoperative pain scores during hospitalization;TNF-alpha;IL-1 beta;Incidence of pulmonary complications;IL-1 alpha;

Secondary Outcome Measures

Name	Time	Method
The occurrence of adverse events;